Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma

被引:2
|
作者
Huang, Tingting [1 ]
Tian, Wei [1 ]
Zhou, Qingqing [1 ]
Li, Jiajun [1 ]
Jiang, Zhiyuan [1 ]
Chen, Jinsi [1 ]
Ge, Chao [1 ]
Tian, Hua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Rpn10; prognosis; NE-kappa B; clear cell renal cell carcinoma; HEPATOCELLULAR-CARCINOMA; PROTEASOME; CANCER; MIGRATION;
D O I
10.1093/abbs/gmab078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin-proteasome system (UPS) plays a central role in regulating protein homeostasis in tumor progression. The proteasome subunit Rpn10 is associated with the progression of several tumor types. However, little is known regarding the role of Rpn10 in clear cell renal cell carcinoma (ccRCC). In this study, we found that overexpression of Rpn10 increased ccRCC cell proliferation, migration, and invasion. Silencing Rpn10 expression resulted in decreased cell proliferation, migration, and invasion in ccRCC cells. Knockdown of Rpn10 inhibits tumor growth and cell proliferation in vivo. Furthermore, we demonstrated that Rpn10 increased cell proliferation, migration, and invasion via regulation of the nuclear factor kappa B (NE-kappa B) pathway. Rpn10 directly promoted inhibitor of nuclear factor-kappa B alpha (I kappa B alpha) degradation through the UPS. Moreover, we observed that upregulation of Rpn10 or downregulation of I kappa B alpha in ccRCC was associated with poor prognosis. We found that the combination of these two parameters was a more powerful predictor of poor prognosis than either parameter alone. Collectively, these findings provide evidence that Rpn10 promotes the progression of ccRCC by regulation of the NE-kappa B pathways and is a prognostic indicator for patients with ccRCC.
引用
收藏
页码:988 / 996
页数:9
相关论文
共 50 条
  • [1] GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma
    Chen, Shi-lu
    Huang, Qun-sheng
    Huang, Yu-hua
    Yang, Xia
    Yang, Ming-ming
    He, Yang-fan
    Yun, Cao
    Guan, Xin-yuan
    Yun, Jing-ping
    THERANOSTICS, 2020, 10 (20): : 9186 - 9199
  • [2] CARD10 promotes the progression of renal cell carcinoma by regulating the NF-κB signaling pathway
    Peng, Longfei
    He, Ke
    Cao, Zhangjun
    Bi, Liangkuan
    Yu, Dexin
    Wang, Qi
    Wang, Jinyou
    MOLECULAR MEDICINE REPORTS, 2020, 21 (01) : 329 - 337
  • [3] PPARα mediates sunitinib resistance via NF-κB activation in clear cell renal cell carcinoma
    Aimudula, Ainiwaer
    Nasier, Huerxidan
    Yang, Ying
    Zhang, Ruili
    Lu, Pengfei
    Hao, Jie
    Bao, Yongxing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2389 - 2400
  • [4] MicroRNA-10b Promotes Apoptosis via JNK Pathway in Clear Cell Renal Cell Carcinoma
    Qin, Jianyang
    Zhou, Jia
    Teng, Ling
    Han, Ying
    NEPHRON, 2018, 139 (02) : 172 - 180
  • [5] APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progression
    Hase, Nora
    Misiak, Danny
    Taubert, Helge
    Huettelmaier, Stefan
    Gekle, Michael
    Koehn, Marcel
    MOLECULAR ONCOLOGY, 2025, 19 (01) : 114 - 132
  • [6] SPOP promotes tumor progression via activation of -catenin/TCF4 complex in clear cell renal cell carcinoma
    Zhao, Wencai
    Zhou, Jiancheng
    Deng, Zhuo
    Gao, Yang
    Cheng, Yongyi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (03) : 1001 - 1008
  • [7] CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
    Qi Wang
    Jiaju Xu
    Zhiyong Xiong
    Tianbo Xu
    Jingchong Liu
    Yuenan Liu
    Jiaping Chen
    Jian Shi
    Yi Shou
    Changjie Yue
    Di Liu
    Huageng Liang
    Hongmei Yang
    Xiong Yang
    Xiaoping Zhang
    Journal of Translational Medicine, 19
  • [8] CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
    Wang, Qi
    Xu, Jiaju
    Xiong, Zhiyong
    Xu, Tianbo
    Liu, Jingchong
    Liu, Yuenan
    Chen, Jiaping
    Shi, Jian
    Shou, Yi
    Yue, Changjie
    Liu, Di
    Liang, Huageng
    Yang, Hongmei
    Yang, Xiong
    Zhang, Xiaoping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [9] FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway
    Shen, Haixiang
    Ying, Yufan
    Ma, Xueyou
    Xie, Haiyun
    Chen, Shiming
    Sun, Jiazhu
    Liu, Zixiang
    Wen, Chao
    Yang, Zitong
    Wang, Xiao
    Xu, Mingjie
    Luo, Jindan
    Liu, Ben
    Li, Jiangfeng
    Zheng, Xiangyi
    Xie, Liping
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [10] FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway
    Haixiang Shen
    Yufan Ying
    Xueyou Ma
    Haiyun Xie
    Shiming Chen
    Jiazhu Sun
    Zixiang Liu
    Chao Wen
    Zitong Yang
    Xiao Wang
    Mingjie Xu
    Jindan Luo
    Ben Liu
    Jiangfeng Li
    Xiangyi Zheng
    Liping Xie
    Cell Death Discovery, 8